Olema Pharmaceuticals, Inc. (OLMA)
Across 22 earnings reports since Mar 17, 2021, Olema Pharmaceuticals, Inc. (OLMA) has a clear post-earnings pattern. It moves ±8.20% on average after reporting and finishes higher 50.0% of the time. Its largest post-earnings gain was +16.19% (Aug 11, 2025) and its largest decline was -26.74% (Aug 09, 2022). The next earnings report is predicted for 2026-08-07 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±8.20%
Positive %
50.0%
Negative %
50.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | ☀ PRE | $14.55 | $14.58 | $13.97 | 129,757 | -6.02% | open_in_new |
| Mar 16, 2026 | ☀ PRE | $15.10 | $16.80 | $16.60 | 2,250,100 | +12.85% | open_in_new |
| Nov 10, 2025 | ☀ PRE | $8.35 | $8.83 | $8.70 | 723,000 | +4.19% | open_in_new |
| Aug 11, 2025 | ☽ POST | $4.64 | $4.78 | $4.57 | 315,300 | +16.19% | open_in_new |
| May 13, 2025 | ☽ POST | $4.78 | $4.88 | $4.68 | 528,900 | -3.85% | open_in_new |
| Mar 18, 2025 | ☽ POST | $4.36 | $4.36 | $4.14 | 487,500 | -0.72% | open_in_new |
| Nov 12, 2024 | ☽ POST | $12.56 | $12.78 | $11.54 | 650,400 | -0.52% | open_in_new |
| Aug 06, 2024 | ☽ POST | $13.84 | $14.28 | $13.94 | 336,800 | -9.9% | open_in_new |
| May 08, 2024 | ☽ POST | $10.96 | $11.02 | $10.85 | 611,200 | -9.31% | open_in_new |
| Mar 11, 2024 | ☽ POST | $13.05 | $13.79 | $13.00 | 990,500 | -6.62% | open_in_new |
| Nov 07, 2023 | ☽ POST | $15.07 | $16.80 | $16.62 | 496,600 | +3.13% | open_in_new |
| Aug 08, 2023 | ☽ POST | $9.10 | $9.93 | $9.46 | 182,700 | +12.05% | open_in_new |
| May 09, 2023 | ☽ POST | $6.57 | $7.42 | $7.27 | 194,200 | -8.67% | open_in_new |
| Mar 09, 2023 | ☽ POST | $3.89 | $3.97 | $3.76 | 64,500 | +3.46% | open_in_new |
| Nov 08, 2022 | ☽ POST | $3.01 | $3.31 | $3.13 | 108,000 | -5.11% | open_in_new |
| Aug 09, 2022 | ☽ POST | $5.63 | $5.94 | $5.61 | 133,100 | -26.74% | open_in_new |
| May 09, 2022 | ☽ POST | $2.20 | $2.22 | $2.06 | 257,900 | +6.8% | open_in_new |
| Feb 28, 2022 | ☽ POST | $4.40 | $4.78 | $4.68 | 438,300 | +14.96% | open_in_new |
| Nov 10, 2021 | ☽ POST | $26.94 | $28.39 | $26.78 | 334,600 | +1.16% | open_in_new |
| Aug 10, 2021 | ☽ POST | $26.02 | $26.12 | $25.93 | 338,000 | +4.94% | open_in_new |
| May 11, 2021 | ☽ POST | $21.27 | $22.18 | $21.67 | 125,500 | +12.97% | open_in_new |
| Mar 17, 2021 | ☽ POST | $49.22 | $50.98 | $49.67 | 194,000 | -10.23% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±8.20%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260526 | open_in_new SEC.gov |
| 8-K | 20260521 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 8-K | 20260501 | open_in_new SEC.gov |
| 4 | 20260429 | open_in_new SEC.gov |
| 3 | 20260429 | open_in_new SEC.gov |
| ARS | 20260429 | open_in_new SEC.gov |
| DEFA14A | 20260429 | open_in_new SEC.gov |
| DEF 14A | 20260429 | open_in_new SEC.gov |
Frequently asked about OLMA earnings
When does Olema Pharmaceuticals, Inc. report earnings next? expand_more
Olema Pharmaceuticals, Inc. (OLMA)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does OLMA stock move after earnings? expand_more
Over 22 reports, OLMA has moved an average of ±8.20% the session after earnings, closing higher 50.0% of the time.
What was OLMA's biggest post-earnings move? expand_more
OLMA's largest post-earnings gain on record was +16.19% on Aug 11, 2025, and its largest decline was -26.74% on Aug 09, 2022.
Where can I find Olema Pharmaceuticals, Inc.'s SEC filings? expand_more
All of Olema Pharmaceuticals, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right